Rankings
▼
Calendar
ARVN Q4 2025 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$907M
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$10M
-84.0% YoY
Gross Profit
$8M
87.4% margin
Operating Income
-$72M
-754.7% margin
Net Income
-$67M
-709.5% margin
EPS (Diluted)
$-1.04
QoQ Revenue Growth
-77.3%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$31M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$718M
Total Liabilities
$284M
Stockholders' Equity
$434M
Cash & Equivalents
$143M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$59M
-84.0%
Gross Profit
$8M
$59M
-86.0%
Operating Income
-$72M
-$58M
-23.2%
Net Income
-$67M
-$45M
-49.4%
← FY 2025
All Quarters